Inovio Pharmaceuticals, Inc. (INO) has a market capitalization of $59.48M and trades at $1.11. The 52-week range is 1.07-2.98.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.6, Earnings Per Share (EPS) of $-1.81, annual revenue of $65.34K.
The stock has a beta of 1.70, operates in the Healthcare sector.
